One of the Yamanaka factors used to rejuvenate cells, KLF4, has been shown to be a potential new IPF target thanks to its ability to restore TERT activity and prevent telomere attrition in lung epithelium [89]. Here, TERT is linked to idiopathic pulmonary fibrosis.